Titre : Facteurs de transcription EGR

Facteurs de transcription EGR : Questions médicales fréquentes

Termes MeSH sélectionnés :

Implementation Science
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Facteurs de transcription EGR : Questions médicales les plus fréquentes", "headline": "Facteurs de transcription EGR : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Facteurs de transcription EGR : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-08", "dateModified": "2025-05-03", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Facteurs de transcription EGR" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Facteurs de transcription", "url": "https://questionsmedicales.fr/mesh/D014157", "about": { "@type": "MedicalCondition", "name": "Facteurs de transcription", "code": { "@type": "MedicalCode", "code": "D014157", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-1", "alternateName": "Early Growth Response Protein 1", "url": "https://questionsmedicales.fr/mesh/D051766", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-1", "code": { "@type": "MedicalCode", "code": "D051766", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.500" } } }, { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-2", "alternateName": "Early Growth Response Protein 2", "url": "https://questionsmedicales.fr/mesh/D051767", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-2", "code": { "@type": "MedicalCode", "code": "D051767", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.750" } } }, { "@type": "MedicalWebPage", "name": "Facteur de transcription EGR-3", "alternateName": "Early Growth Response Protein 3", "url": "https://questionsmedicales.fr/mesh/D051776", "about": { "@type": "MedicalCondition", "name": "Facteur de transcription EGR-3", "code": { "@type": "MedicalCode", "code": "D051776", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.930.213.875" } } } ], "about": { "@type": "MedicalCondition", "name": "Facteurs de transcription EGR", "alternateName": "Early Growth Response Transcription Factors", "code": { "@type": "MedicalCode", "code": "D051765", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "John P Lydon", "url": "https://questionsmedicales.fr/author/John%20P%20Lydon", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA." } }, { "@type": "Person", "name": "Elizabeth Jose", "url": "https://questionsmedicales.fr/author/Elizabeth%20Jose", "affiliation": { "@type": "Organization", "name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Woody March-Steinman", "url": "https://questionsmedicales.fr/author/Woody%20March-Steinman", "affiliation": { "@type": "Organization", "name": "Applied Mathematics, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Lisa Shanks", "url": "https://questionsmedicales.fr/author/Lisa%20Shanks", "affiliation": { "@type": "Organization", "name": "Molecular and Cellular Biology, University of Arizona, Tucson, AZ, 85721." } }, { "@type": "Person", "name": "Vineet K Maurya", "url": "https://questionsmedicales.fr/author/Vineet%20K%20Maurya", "affiliation": { "@type": "Organization", "name": "Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "An implementation science approach to the systematic study of access to gynecologic cancer care.", "datePublished": "2023-03-25", "url": "https://questionsmedicales.fr/article/36972637", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ygyno.2023.03.012" } }, { "@type": "ScholarlyArticle", "name": "MCH Leadership Training Program: An Innovative Application of an Implementation Science Framework.", "datePublished": "2023-02-24", "url": "https://questionsmedicales.fr/article/36828973", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10995-023-03607-6" } }, { "@type": "ScholarlyArticle", "name": "Becoming breastfeeding friendly in Great Britain-Does implementation science work?", "datePublished": "2022-07-19", "url": "https://questionsmedicales.fr/article/35851990", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/mcn.13393" } }, { "@type": "ScholarlyArticle", "name": "Planning an implementation science training program for advanced practice registered nurses.", "datePublished": "2023-09-01", "url": "https://questionsmedicales.fr/article/37102428", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/XEB.0000000000000376" } }, { "@type": "ScholarlyArticle", "name": "Quality improvement in the implementation science paradigm in professional programs: scoping review.", "datePublished": "2023-07-28", "url": "https://questionsmedicales.fr/article/37585956", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/1983-1447.2023.20220159.en" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Facteurs de transcription", "item": "https://questionsmedicales.fr/mesh/D014157" }, { "@type": "ListItem", "position": 5, "name": "Facteurs de transcription EGR", "item": "https://questionsmedicales.fr/mesh/D051765" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Facteurs de transcription EGR - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Facteurs de transcription EGR", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Facteurs de transcription EGR", "description": "Comment diagnostiquer une dysrégulation des EGR ?\nQuels tests sont utilisés pour évaluer les EGR ?\nLes EGR peuvent-ils être mesurés dans le sang ?\nQuels symptômes indiquent une anomalie des EGR ?\nLes EGR sont-ils impliqués dans des maladies spécifiques ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Facteurs de transcription EGR", "description": "Quels symptômes sont liés à une surproduction d'EGR ?\nLes EGR affectent-ils le système immunitaire ?\nQuels signes cliniques sont associés aux EGR ?\nLes EGR sont-ils liés à des troubles mentaux ?\nComment les EGR influencent-ils le développement embryonnaire ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Facteurs de transcription EGR", "description": "Peut-on prévenir les anomalies liées aux EGR ?\nLes facteurs environnementaux influencent-ils les EGR ?\nComment réduire le risque de dysrégulation des EGR ?\nL'exercice physique influence-t-il les EGR ?\nLes suppléments nutritionnels affectent-ils les EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Facteurs de transcription EGR", "description": "Existe-t-il des traitements ciblant les EGR ?\nComment moduler l'activité des EGR ?\nLes EGR peuvent-ils être une cible pour le cancer ?\nQuels médicaments affectent les EGR ?\nLes EGR sont-ils impliqués dans la thérapie cellulaire ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Facteurs de transcription EGR", "description": "Quelles complications peuvent survenir avec des EGR anormaux ?\nLes EGR sont-ils liés à des maladies chroniques ?\nComment les EGR affectent-ils la santé cardiovasculaire ?\nLes EGR peuvent-ils causer des troubles neurologiques ?\nQuelles sont les conséquences d'une surproduction d'EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Facteurs de transcription EGR", "description": "Quels facteurs augmentent le risque de dysrégulation des EGR ?\nLe stress influence-t-il les EGR ?\nL'alimentation joue-t-elle un rôle dans les EGR ?\nLes infections affectent-elles les EGR ?\nL'âge est-il un facteur de risque pour les EGR ?", "url": "https://questionsmedicales.fr/mesh/D051765?mesh_terms=Implementation+Science&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysrégulation des EGR ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les EGR ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les Western blot sont couramment utilisés pour évaluer l'expression des EGR." } }, { "@type": "Question", "name": "Les EGR peuvent-ils être mesurés dans le sang ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de tests sanguins standardisés pour mesurer les EGR." } }, { "@type": "Question", "name": "Quels symptômes indiquent une anomalie des EGR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de croissance ou des troubles neurologiques peuvent indiquer une dysrégulation." } }, { "@type": "Question", "name": "Les EGR sont-ils impliqués dans des maladies spécifiques ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont associés à des maladies comme le cancer et les troubles neurodégénératifs." } }, { "@type": "Question", "name": "Quels symptômes sont liés à une surproduction d'EGR ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner une hyperplasie cellulaire et des troubles de croissance." } }, { "@type": "Question", "name": "Les EGR affectent-ils le système immunitaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils régulent la réponse immunitaire et peuvent influencer l'inflammation." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés aux EGR ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme la fatigue, des douleurs musculaires et des troubles cognitifs peuvent apparaître." } }, { "@type": "Question", "name": "Les EGR sont-ils liés à des troubles mentaux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des études montrent un lien potentiel entre les EGR et des troubles comme la dépression." } }, { "@type": "Question", "name": "Comment les EGR influencent-ils le développement embryonnaire ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils jouent un rôle crucial dans la régulation des gènes nécessaires au développement embryonnaire." } }, { "@type": "Question", "name": "Peut-on prévenir les anomalies liées aux EGR ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certaines anomalies." } }, { "@type": "Question", "name": "Les facteurs environnementaux influencent-ils les EGR ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des facteurs comme le stress et la pollution peuvent affecter leur expression." } }, { "@type": "Question", "name": "Comment réduire le risque de dysrégulation des EGR ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines et maintenir un bon équilibre hormonal peut réduire le risque." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il les EGR ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut moduler l'expression des EGR et améliorer la santé globale." } }, { "@type": "Question", "name": "Les suppléments nutritionnels affectent-ils les EGR ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer leur expression." } }, { "@type": "Question", "name": "Existe-t-il des traitements ciblant les EGR ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours de recherche." } }, { "@type": "Question", "name": "Comment moduler l'activité des EGR ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des agents pharmacologiques et des modifications épigénétiques peuvent moduler leur activité." } }, { "@type": "Question", "name": "Les EGR peuvent-ils être une cible pour le cancer ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les EGR sont des cibles potentielles pour des traitements anticancéreux innovants." } }, { "@type": "Question", "name": "Quels médicaments affectent les EGR ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments anti-inflammatoires peuvent influencer l'expression des EGR." } }, { "@type": "Question", "name": "Les EGR sont-ils impliqués dans la thérapie cellulaire ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, leur régulation est essentielle pour le succès des thérapies cellulaires et régénératives." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des EGR anormaux ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme le cancer, les maladies auto-immunes et les troubles métaboliques peuvent survenir." } }, { "@type": "Question", "name": "Les EGR sont-ils liés à des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une dysrégulation des EGR est associée à des maladies chroniques comme le diabète." } }, { "@type": "Question", "name": "Comment les EGR affectent-ils la santé cardiovasculaire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une régulation anormale des EGR peut contribuer à des maladies cardiovasculaires." } }, { "@type": "Question", "name": "Les EGR peuvent-ils causer des troubles neurologiques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies dans l'expression des EGR sont liées à des troubles neurologiques." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une surproduction d'EGR ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction peut entraîner des tumeurs et des désordres de croissance cellulaire." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de dysrégulation des EGR ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des facteurs comme l'exposition à des toxines et des prédispositions génétiques augmentent le risque." } }, { "@type": "Question", "name": "Le stress influence-t-il les EGR ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter l'expression des EGR et la santé cellulaire." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans les EGR ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en antioxydants peut aider à réguler l'expression des EGR." } }, { "@type": "Question", "name": "Les infections affectent-elles les EGR ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections peuvent moduler l'expression des EGR, influençant la réponse immunitaire." } }, { "@type": "Question", "name": "L'âge est-il un facteur de risque pour les EGR ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut affecter l'expression des EGR et la régulation génétique." } } ] } ] }

Sources (10000 au total)

An implementation science approach to the systematic study of access to gynecologic cancer care.

Barriers to access to cancer care are profoundly threatening to patients with gynecologic malignancies. Implementation science focuses on empirical investigation of factors influencing delivery of cli... Literature on the use of the Consolidated Framework for Implementation Research (CFIR) was reviewed. Delivery of cytoreductive surgery for advanced ovarian carcinoma was selected as an illustrative ca... CFIR domains include Innovation, Inner Setting, Outer Setting, Individuals, and Implementation Process. "Innovation" relates to characteristics of the surgical intervention itself; "Inner Setting" rel... Prioritization of implementation science methods in the study of access to gynecologic cancer care will help ensure that patients are able to utilize interventions with the greatest prospect of benefi...

MCH Leadership Training Program: An Innovative Application of an Implementation Science Framework.

MCH training programs in schools of public health provide specialized training to develop culturally competent and skilled MCH leaders who will play key roles in public health infrastructure. Previous... This article describes a graduate-level MCH leadership training program and illustrates how an implementation science framework can inform the identification of determinants and lessons learned during... Findings reveal how CFIR can be applicable to a MCH training program and highlight how constructs across domains can interact and represent determinants that serve as both a barrier and facilitator. K... Findings may apply to other programs and settings and could advance innovative training efforts that necessitate attention to the multi-level stakeholder needs (e.g., student, program, institution, co...

Planning an implementation science training program for advanced practice registered nurses.

A gap exists between scientific discovery and implementation and adoption of research findings in healthcare and public health practice. This gap is due to the fact that research on treatment efficacy... The objective of this article is to describe the infrastructure established to develop a 3-day implementation training program for APRNs and an implementation support system.... A description of the processes and strategies is provided, including stakeholder engagement through focus groups and the formation of a multistakeholder program planning advisory team, which includes ... Stakeholders were instrumental in shaping the implementation training program, including the content of the curriculum and the program agenda. In addition, the unique perspective of each stakeholder g... It is important that strategies to address the lack of implementation training opportunities for APRNs be discussed and disseminated within the healthcare community. This article discusses the plan to...

Quality improvement in the implementation science paradigm in professional programs: scoping review.

To map knowledge regarding Quality Improvement in the implementation science paradigm in graduate nursing education in professional programs.... This is a scoping review, conducted from October to December 2021, following the assumptions established by the Joanna Briggs Institute and the PRISMA-ScR protocol.... 18 studies were selected. Being, 7 articles (38.8%) about the implementation strategies and development of Quality Improvement projects for graduate nursing students. The included studies emphasize Qu... Implementation science and Quality Improvement projects advance professional programs to improve and develop quality health care....

Implementation Science for Eliminating HIV Among Adolescents in High-Burden African Countries: Findings and Lessons Learned from the Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA).

Eliminating adolescent HIV in high-burden African countries depends on the success of implementing evidence-based interventions to reduce transmission and improve treatment outcomes. The Adolescent HI...

Implementation Science in School-Based, Universal-Level Intervention Research: A Scoping Review.

The aim of this study was to map the use of implementation science frameworks, models, and theories in intervention research targeting learning needs in the classroom.... A scoping review was conducted. Electronic database and manual searches were conducted. Two reviewers independently completed screening, data extraction, and quality appraisal. Qualitative content ana... Included papers (... Early engagement with stakeholders in education is recommended when designing universal level speech, language, and communication interventions for use in the ordinary classroom. Adaptive, hybrid desi...